MLN4924 (905579-51-3) is a potent and selective NEDD8-activating enzyme (NAE) inhibitor. Disrupts cullin-RING ligase-mediated protein turnover leading to apoptosis in human tumor cells. Supresses the growth of tumor xenografts in mice. Cell permeable.
1) Soucy et al. (2009), An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer; Nature, 458 732
2) Milhollen et al. (2010) MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-(kappa)B-dependent lymphoma; Blood, 116 1515